Insider · CIK 0002098854
Stephen Ralph Gertz
Files at QMLS (QumulusAI, Inc.). First filing -, latest -.
Stephen Ralph Gertz files SEC Form 4 as officer at QMLS (QumulusAI, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen Ralph Gertz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | QMLS QumulusAI, Inc. | AGrant or award Common Stock | +46,848 | $0.00 | $0 | 98,558 | 41 d ago |
| Sep 1, 2026 | QMLS QumulusAI, Inc. | AGrant or award Common Stock | +58,329 | $0.00 | $0 | 156,887 | 41 d ago |
| Sep 1, 2026 | QMLS QumulusAI, Inc. | AGrant or award Common Stock | +90,112 | $0.00 | $0 | 246,999 | 41 d ago |
| Sep 1, 2026 | QMLS QumulusAI, Inc. | AGrant or award Common Stock | +19,165 | $0.00 | $0 | 266,164 | 41 d ago |
Questions about Stephen Ralph Gertz
Answered from the filings on this page, as of the latest one.
Is Stephen Ralph Gertz buying or selling?
Stephen Ralph Gertz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen Ralph Gertz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen Ralph Gertz has 0.
Where does Stephen Ralph Gertz file Form 4?
Stephen Ralph Gertz has filed Form 4 at QMLS (QumulusAI, Inc.) as Chief Growth Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.